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Summary
Corticotropin-releasing factor (CRF) study
Background: Hypothalamic pituitary adrenal (HPA)-axis dysfunction is a
common symptom of patients with anxiety disorders like posttraumatic stress
disorder (PTSO), panic disorder and obsessive-compulsive disorder (OCD).
Depressive patients also have HPA-axis dysfunction similar to patients with
anxiety disorders. PTSD patients usually show decreased basal plasma cortisol
levels whereas OCD and depressive patients show an increase in plasma
cortisol. A blunted adrenocorticotropin hormone (ACTH) response to CRF is
seen in these patients and mostly an increased level of CRF in their
cerebrospinal fluid (CSF). It has been proposed that the CSF level of CRF is a
reflection of activity of both hypothalamic and extra-hypothalamic CRF systems.
Since the amygdala has been shown to be involved in the endocrine and
behavioural response to stress, and CRF is involved in the mediation of this
response, we investigated whether chronic elevation of CRF in the amygdala is
involved in development of the symptoms of psychiatric disorders. We
chronically injected rats with CRF in this area to see what the effect is on their
behaviour and HPA-axis response. It has been shown that the hippocampal
serotonergic (5-HT) system is involved in both anxiety and depression and that
the 5-HT system is regulated by CRF. We therefore measured hippocampal 5-
HT1A receptor density and affinity in CRF-injected and control rats.
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vMaterials and methods: Male Sprague-Dawley and Wistar rats were
stereotaxically implanted with unilateral and bilateral chronic cannulae in the
basolateral amygdala (BLA). After recovery unilaterally implanted rats were
injected with 10ng (n=7) or 1DOng(n=6) of CRF or saline (n=6) daily for 5 days.
Behaviour was tested on day 5 in the elevated plus-maze and open field. Rats
with bilateral implants were injected with 100ng CRF (n=19) or saline (n=17) on
either side for 5 days. On day 5, behaviour was tested on the elevated plus-
maze and open field. Group 1 was tested at baseline levels (n=6 for saline and
n=7 for CRF) and group 2 after 5 min. of restraint (n=11 for saline and n=12 for
CRF). The stress response of all rats was tested 2 days later. The rats were
divided into 3 groups: The first group was decapitated at baseline level (n=6 for
each group), the second and third groups restrained for 10 min. and decapitated
15 min. (n=6 for saline and n=7 for CRF) and 60 min. (n=5 for saline and n=6 for
CRF) after restraint stress. Blood was collected for plasma ACTH and
corticosterone determinations. A group of naïve rats was also included in this
experiment to control for the possible effect of the operation (n=6 for each time
point). Hippocampi were dissected out and used for 5-HT1A radioligand binding
studies.
Results: Rats that were unilaterally injected with 1DOngCRF, showed significant
increase in the amount of entries into the open arms as well as the amount of
time spent in the open arms of the elevated plus-maze compared to controls and
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rats injected with 10ng CRF. There were no differences between the groups in
other parameters of the elevated plus-maze or open field behaviour. There were
no significant differences in behaviour of bilateral injected rats compared to
controls, but an increase of grooming in the open field was observed in CRF-
injected rats that were stressed before behavioural tests. The ACTH and
corticosterone response of rats were normal as seen by a significant increase in
both concentrations 15 min. after stress and a return to near basal values 60 min.
post stress. There were no differences in plasma ACTH concentrations between
the groups at any time point. The basal corticosterone level of CRF-injected rats
was however significantly lower than controls, but no difference were found 15 or
60 min. post stress. There were no significant differences in hippocampal 5-HT1A
receptor densities or affinities of CRF-injected and control rats.
Conclusions: We did not observe increased anxiety levels or decreased activity
in CRF injected rats. Instead, we observed increased activity in unilateral
injected rats. We suspect that the lower dosage of CRF may have this effect on
the behaviour of rats, since other authors have also found this result. The lack of
differences in the 5-HT1A receptor populations of CRF-injected rats and control
rats also confirms this result, since there was no increase in anxiety levels of
CRF-injected rats. The chronic elevation of CRF in the SLA caused decreased
basal levels of corticosterone in the rats and we speculate that CRF caused
adrenal insufficiency although the mechanism is unknown.
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Stereotypical behaviour study
Background: OCD affects 1-2% of the adult human population and is amongst
the most common psychiatric disorders. This disorder is characterized by
obsessions and compulsions. These compulsions or repetitive behaviours are
suggested to be the cause of a hyperactive cortical-striatal-thalamic-cortical
(CSTC) circuit in the brain, because of imbalance of the direct and indirect
pathways. CSTC pathways are modulated by both 5-HT and dopaminergic (DA)
neurons and it has been suggested that a hyperglutamatergic state exists in the
frontal cortex of OCD patients. Two types of animal models of stereotypical
behaviour are used to investigate neurotransmitter abnormalities related to OCD.
These are drug induced stereotypies and environmentally induced (spontaneous)
stereotypies. It has been shown that in deermice (Peromyscus manicula tis) ,
drug induced stereotypies are topographically different from spontaneous
stereotypies, and our aims were to characterize a deermice model of
spontaneous stereotypy for OCD in terms of face, predictive and construct
validity. We injected adult deermice, showing spontaneous stereotypies, for a
time period of 8 weeks with risperidone (D2/5-HT2 antagonist), citalopram
(selective serotonin reuptake inhibitor) and inositol (a metabolic precursor to the
phosphatidylinositol second messenger cycle). All these drugs have been shown
to improve symptoms of OCD in humans, and we investigated whether the drugs
can reduce stereotypies in deermice.
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Materials and methods: 40 Adult deermice were raised and housed in standard
laboratory cages and randomly divided into four groups (6 females and 4 males
per group). After baseline recordings of behaviour (3 times per week for a total
of 15 min.) the mice were injected daily for 8 weeks with risperidone, citalopram,
inositol or saline. Video recordings were made for the 8 week trial and rated
afterwards by raters that were blind to the medication status of the animals. A 5
sec. interval scoring system was used for ratings in which the absence or
presence of a stereotypy (backward somersault) was noted. After 8 weeks of
treatment, the mice were decapitated, brains were dissected and the frontal
cortices were stored in liquid nitrogen until radioligand binding studies were
performed on NMDA receptors.
Results: There were no significant differences in the amount of somersaults
between saline injected and drug treated groups when the data was analysed
using an ANOVA with repeated measures. There was a significant difference
between the control group and drug treated groups at week 8 in male mice when
the data was analysed using a Mann-Whitney test. The amount of somersaults
shown by saline injected mice increased over the 8 week trial while it stayed
more constant in all three drug treated groups. There were no significant
differences between the control group and treatment groups in Bmax and Kd
values of NMDA receptors in the frontal cortex. There was a trend towards
increased receptor densities in all treatment groups compared to the control
group and a decrease in affinity in the risperidone group.
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Conclusions: We found limited evidence for the involvement of both 5-HT and
DA systems in the development of spontaneous stereotypical behaviour of
deermice. Risperidone, citalopram and inositol were useful in suppressing the
increase in somersaults observed in the control group towards week 8 of the trial.
This increase was presumably due to stress from handling and injections. The
fact that there was a trend towards increased receptor densities in all treatment
groups and decreased affinity in the risperidone group also point to the
involvement of 5-HT and DA in spontaneous stereotypies. The limitation of this
study was small group numbers and excessive stress experienced by the
animals.
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Kortikotropien vrystellingsfaktor (CRF) studie
Agtergrond: Hipotalamus-hipofise-adrenale (HPA)-as abnormaliteite is 'n
algemene simptoom van pasiente wat gediagnoseer is met verskeie psigiatriese
afwykings soos posttraumatiese stres steuring (PTSO), obsessiewe-kompulsiewe
steuring (OCD) paniek steuring en depressie. PTSD pasiente toon gewoonlik 'n
verlaging in basale kortisol vlakke, terwyl OCD en depressie pasiente "n
verhoging in die basale konsentrasie van kortisol in die bloed toon. 'n Verlaagde
adrenokortikotropien hormoon (ACTH) respons na toediening van CRF word ook
gewoonlik in al die bogenoemde afwykings waargeneem. Pasiente toon ook 'n
verhoging in CRF konsentrasies in hul cerebrospinale vloeistof (CSF). Daar is
voorheen al bewyse gevind dat die CRF konsentrasie in CSF 'n aanduiding van
beide die aktiwiteit van die HPA-as en ander CRF sisteme verteenwoordig. Die
amygdala is 'n belangrike deel van die brein wat betrokke is by die endokriene en
gedragsrespons op stres. Omdat CRF aangedui is om 'n rol te speel in die stres
respons, het ons ondersoek ingestel na die rol van kroniese verhoging van CRF
in die amygdala in die ontwikkeling van simptome van psigiatriese steuringe.
Rotte is kronies ingespuit in hierdie brein area en die effek daarvan is
waargeneem deur na die gedrag en stres respons van die rotte te kyk. Dit is ook
al aangedui dat die serotonergiese (5-HT) sisteem in die hippokampus betrokke
is in angstigheid en depressie, en dat hierdie sisteem gereguleer word deur CRF.
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Daarom het ons ook ondersoek ingestelof daar verskille is in die 5-HT1A reseptor
populasies van CRF en kontrole rotte.
Materiale en metodes: Manlike Sprague-Dawley en Wistar rotte is
onderskeidelik met behulp van stereotaksis met chroniese kannules unilateraal
en bilateraal geinplanteer in die basolaterale nukleus van die amygdala (BLA).
Nadat die rotte herstel het, is rotte met unilaterale inplanterings ingespuit met
10ng (n=7) of 100ng (n=6) CRF of 'n soutoplossing (n=6) daagliks vir 5
agtereenvolgende dae. Hierdie rotte se gedrag is waargeneem op die 5de dag
met behulp van die "elevated plus-maze" en "open field". Rotte met bilaterale
inplanterings is daagliks ingespuit met 100ng CRF (n=19) of soutoplossing
(n=17) vir 5 dae. Die gedrag is op dieselfde manier getoets op die vyfde dag
behalwe dat een groep vir 5 min gestres was voor die toets (n=11 vir kontrole en
n= 12 vir CRF) terwyl die ander groep rotte waargeneem is by basale vlakke (n=6
vir kontrole en n=7 vir CRF). Die stres respons van hierdie rotte is ook 2 dae
later getoets. Die rotte is verdeel in 3 groepe waarvan die eerste groep
gedekapiteer is by basale vlakke (n=6 vir kontrole en CRF). Die tweede en
derde groepe is blootgestel aan 10 min. stres en gedekapiteer onderskeidelik 15
min. (n=6 vir kontrole en n=7 vir CRF) en 60 min. (n=5 vir kontrole en n=6 vir
CRF) na die stres periode. Bloed is opgevang vir plasma ACTH en
kortikosteroon bepalings. 'n Groep naiewe rotte is ook ingesluit in hierdie
eksperiment om te kontroleer vir die effek wat die operasie kon hê (n=6 vir elke
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tydstip). Die breine is gedissekteer en hippokampusse verwyder en gestoor in
vloeibare stikstof vir radioligand bindingstudies op 5-HT1A reseptore.
Resultate: Rotte wat unilaterale CRF inspuitings gekry het, het "n beduidende
verhoging getoon in die aantal tyd gespandeer en die aantal kere wat hulle die
oop arms van die "elevated plus-maze" binnegegaan het in vergelyking met
kontrole rotte. Daar was geen verskil tussen die groepe in enige van die ander
parameters waargeneem in die "elevated plus-maze" of "open field" gedrag nie.
Daar was ook geen beduidende verskil in enige gedrag van rotte wat bilateraal
ingespuit is en kontrole rotte nie, behalwe dat daar "n verhoging was in die totale
aantal kere wat die rot versorgingsgedrag getoon het. Die ACTH en
kortikosteroon respons van die rotte was normaal in vergelyking met kontrole
rotte soos waargeneem deur die beduidende verhoging in konsentrasies 15
minute na stres en die verlaging daarvan na 60 minute. Daar was geen verskille
tussen die groepe in die konsentrasies van ACTH nie, maar daar was wel "n
beduidend verlaagde basale konsentrasie van kortikosteroon in die CRF groep in
vergelyking met kontrole rotte. Daar was ook geen verskil in die 5-HT1A reseptor
populasies van die CRF en kontrole rotte nie.
Gevolgtrekkings: Ons het geen verhoging in angstigheid of verlaging in
aktiwiteitsvlakke waargeneem in die CRF rotte nie. Ons het inteendeel
verhoogde aktiwiteitsvlakke waargeneem by CRF rotte wat unilateraal ingespuit
was. Ons vermoed dat die lae dosis van CRF hierdie effek teweeg gebring het in
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die gedrag van die rotte aangesien vorige outeurs ook al hierdie resultaat
waargeneem het. Die afwesigheid van verskille in die reseptor populasies van
die eRF en kontrole rotte bevestig ons resultaat van die gedragstudie aangesien
daar geen verhoging was in anstigheid in eRF rotte nie. Die kroniese verhoging
van eRF vlakke in die SLA het In verlaging in basale vlakke van kortikosteroon
veroorsaak en, alhoewel die meganisme onbekend is, moontlik die adrenale
funksie verlaag.
Stereotiepe gedrag studie
Agtergrond: 1-2% Van volwassene mense word gediagnoseer met OeD, wat
beteken dat dit een van die mees algemene psigiatriese afwykings is. Hierdie
afwyking word gekarakteriseer deur obsessies en kompuisies. Dit is bekend dat
kompuisies of stereotiepe gedrag voorkom as gevolg van In ooraktiewe korteks-
striatum-talamus-korteks (eSTe) sisteem in die brein, as gevolg van In
wanbalans tussen die direkte en indirekte paaie. Die eSTe sisteem word
gereguleer deur 5-HT en dopamien (DA) neurone en dit is al voorgestel dat In
hiperglutamatergiese toestand in die frontale korteks van OeD pasiente bestaan.
Twee tipes dier modelle word gebruik om stereotiepe gedrag te bestudeer in
terme van neurotransmitter abnormaliteite. Die eerste is dwelm-geinduseerde
stereotiepe gedrag en die tweede omgewing-geinduseerde of spontane
stereotiepe gedrag. In Vorige studie op muise (Peromyscus maniculatis) het
getoon dat dwelm-geinduseerde en spontane stereotiepe gedrag verskillend is in
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hierdie spesie. Die doel van ons studie was om In muis model vir OCD te
karakteriseer. Ons het dus volwasse muise wat spontane stereotiepe gedrag
toon vir In tydperk van 8 weke ingespuit met risperidoon, citalopram, inositol of In
soutoplossing. Hierdie medikasie word reeds gebruik vir die behandeling van
mense met OCD en die doel van ons studie was om te sien of dit ook spontane
stereotiepe gedrag in muise kan verminder.
Materiale en metodes: 40 Volwasse muise is geteel en aangehou in standaard
laboratorium hokke en lukraak verdeel in vier groepe met 6 wyfies en 4
mannetjies per groep. Video opnames is vir 9 weke gemaak vir 5 minute per
keer met In totaal van 15 minute per week. Die eerste week is geneem as
basislyn en die muise is daagliks ingespuit met die onderskeie medikasie vir die
volgende 8 weke. Die onderskeie groepe is ingespuit met risperidoon,
citalopram, inositol of In soutoplossing. In 5 Sekonde interval sisteem is gebruik
om gedrag waar te neem, en die teenwoordigheid of afwesigheid van stereotiepe
gedrag is genoteer. Na 8 weke van behandeling is die muise opgeoffer deur
dekapitasie en die breine is gedissekteer en die frontale korteks gebruik vir
radioligand studies op NMDA reseptore.
Resultate: Daar was geen beduidende verskille in stereotiepe gedrag tussen die
kontrole groep en behandelde groepe tussen die basislyn en week 8 wanneer die
data geanaliseer is met behulp van In ANOVA met herhaalde waarnemings nie.
Daar was wel In beduidende verskil tussen die kontrole groep en die behandelde
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groepe by mannetjies in week 8 wanneer die data met "n Mann-Whitney toets
geanaliseer word. Die aantal stereotiepe gedrag in die kontrole groep het
vermeerder oor die 8 week tydperk terwyl dit meer konstant gebly het in
behandelde groepe. Daar was geen beduidende verskille in die digtheid en
affiniteit van NMDA reseptore van kontrole en behandelde groepe nie. Daar was
wel "n neiging tot "n toename in reseptor digtheid by al die behandelde groepe in
vergelyking met die kontrole groep en "n afname in affiniteit in die risperidoon
groep in vergelyking met die kontrole groep.
Gevolgtrekkings: Ons het beperkte bewyse gevind vir die betrokkenheid van
beide 5-HT en DA neurotransmitter sisteme in die ontwikkeling van spontane
stereotiepe gedrag in die muise. Risperidoon, citalopram en inositol het die
toename in stereotiepe gedrag, soos waargeneem in die kontrole groep,
onderdruk. Hierdie toename in stereotiepe gedrag was waarsynlik as gevolg van
uitermatige stres wat die muise ervaar het as gevolg van hantering en
inspuitings. Die feit dat daar "n neiging tot toename in reseptor digthede in al die
behandelde groepe en afname in affiniteit was in die risperidoon groep dui ook
op die betrokkenheid van 5-HT en DA in spontane stereotiepe gedrag. Die
beperkings van hierdie studie was die klein groep nommers en uitermatige stres
wat die muise ervaar het.
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1Chapter 1:
Literature Review
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21.1 Corticotropin-Releasing Factor Study
1.1.1 Stress response
When an animal is exposed to stressors (hostile environment), a series of
coordinated responses are initiated, namely alterations in behaviour, autonomic
function and the secretion of multiple stress hormones (Van de Kar & Blair,
1999). Collectively, these events are called the stress response. The stressor
can either be psychological, for example exposing animals to a novel
environment, or physical, such as giving an animal an electrical foot shock (Van
de Kar & Blair, 1999). An important part of the neuroendocrine pathways in the
stress response is the activation of the hypothalamic-pituitary-adrenal (HPA)
axis. Corticotropin-releasing factor (CRF) is a 41 amino acid peptide
characterised by Vale et al. in 1981 and was the first of the hypothalamic-
releasing factors to be named. CRF is synthesized by neurons of the
paraventricular nucleus of the hypothalamus and, during stress, released into the
portal circulation to reach the anterior pituitary, where it stimulates the release of
ACTH (Cole & Sawchenko, 2002). Adrenocorticotropin hormone (ACTH) in turn
stimulates glucocorticoid release from the adrenal cortex, mainly cortisol in
humans and corticosterone in rats. This is necessary for maintaining
homeostasis in the body (Habib et ai., 2001).
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3Glucocorticoids regulate the HPA-axis and terminate the stress response by
means of negative feedback inhibition at the level of the hypothalamus and
pituitary (De Kloet 1995); see fig.1.1. In addition, extrahypothalamic structures
also participate in the regulation of HPA-axis activity eg. the limbic system.
There are two types of glucocorticoid receptors involved in this regulation. The
type 1 mineralocorticoid receptor (MR) has a high affinity for glucocorticoids and
mediates the effects of corticosterone on the maintenance of basal HPA activity.
These receptors appear to set the threshold of the central stress response
system. The type 2 glucocorticoid receptor (GR) is found in high densities in the
limbic system and is occupied during times of higher circulating corticosterone
levels such as during stress when the glucocorticoid concentration may increase
to about 100-fold. Glucocorticoid binding to these receptors suppresses
subsequent HPA activation. The affinity of corticosterone is about 10 times
higher for the MR receptor than the GR receptor (McEwen et al., 1986; De Kloet
et al., 1998).
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CRF SECRETION
Anterior Pituitary
ACTH SECRETION
Adrenal cortex
t CORTISOL SECRETION
Target cells of cortisol
RESPOND TO INCREASED CORTISOL
Fig.1.1. The HPA-axis and negative feedback inhibition (Adapted from: Vander,
Sherman & Luciano, 1994).
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51.1.2 eRF and behavioural responses to stress
Activation of the HPA-axis is not the only function of CRF in the brain. Adaptive
behavioural changes are an important component of the stress response, and
this may involve extrahypothalamic CRF systems (Koob et aI., 1993).
Immunochemical studies have shown the presence of CRF cell bodies and fibres
in the cortex, limbic system, substantia nigra and locus coeruleus. There is also
evidence that CRF has a neurotransmitter role in the brain (Dunn & Berridge,
1990). Smith et al. (1986) found irCRF release from minced tissue of the
amygdala, striatum and midbrain after potassium stimulation in the presence of
calcium, while Suda et al. (1985) found potassium-induced release of irCRF from
rat hypothalami in vitro. The actions of CRF are mediated through two G-protein
coupled receptors, CRF1 and CRF2. The two receptor subtypes have a unique
distribution in the rat brain and CRF1 receptors are abundant in the pituitary,
cerebellum, brain stem, amygdala and cortex, while the CRF2 receptors are
found in the lateral septum, ventromedial hypothalamus, choroid plexus and
olfactory bulb (Chalmers et aI., 1995). It has been demonstrated that, during
stress, CRF enhanced behavioural suppression and increased freezing,
facilitated conditioned fear, and decreased exploration and feeding (Koob et aI.,
1993). Selective blocking of CRF1 receptors with antagonists promoted anxiolytic
responses in the elevated plus-maze, light-dark box, mouse defense test battery
and the fear-potentiated startle test (Griebel et aI., 1998; Lundkvist et aI., 1996;
Okuyama et aI., 1999). Finally, CRF1 knockout mice showed increased anxiolytic
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6activity in the elevated plus-maze and a tendency to enter the illuminated region
of the light-dark box (Smith et aI., 1998). Findings such as these suggest that
CRF has anxiety provoking behavioural effects. Considering the important role
for CRF in mediating the physiological and behavioural response to stress, it can
be argued that disturbances in the control of CRF synthesis and release may
compromise homeostasis and stress adaptation of an organism, and can result in
pathophysiology, including major depression and anxiety (Groenink et ai., 2003).
The behavioural effect of intracerebroventricular (ICV) administration of CRF has
been thoroughly investigated in rats. CRF administered in non-stressed rats
produces a dose-dependent behavioural activation or increase in locomotion,
rearing and grooming when animals are tested in a familiar environment.
Animals that are exposed to a novel or stressful environment after CRF
administration, show behaviour reminiscent of that observed during stress (Koob
& Heinrichs, 1999).
Rats chronically infused with CRF at a dose of 4.9j..Jg/dayfor 7 days ICV spent
significantly less time in the open arms of the elevated plus-maze and made less
entries into the open arms (Buwalda et ai., 1997), while 3j..Jg/dayCRF for 5 days
decreased the amount of entries into the closed arms (Pietersen, 2001) and
tuq/day for 5 days decreased time spent in the open arms (Song et aI., 1995). In
contrast to these observations, Song et al. (1995) also found that chronic
infusions of 0.1, 0.5 and 1j..JgCRF dose dependently increase activity and rearing
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7in the open field and Linthorst et al. (1997) also found increased activity after
eRF infusion of 1IJg/IJI/hourfor 7 days.
Acute lev administration of 1IJg eRF in rats produced behavioural activation
(Matsuzaki et al., 1989). Britton et al. (1982) found decreased rearing and food
approach behaviour in rats acutely injected with 150pmol eRF. eRF produced a
dose-dependent increase in locomotor activity while it increased freezing and
decreased locomotion in a novel open field (Koob et al., 1993). Sutton et al.
(1982) found similar results as 0.15 and 1.5nmol eRF increased locomotion,
rearing and grooming in a familiar cage while 0.15nmol eRF decreased
locomotion and rearing and increased freezing in a novel open field.
These data show that some researchers found eRF to have anxiogenic
properties and decreases locomotor activity, while others reported opposite
effects. The exact role of eRF in behaviour therefore remains controversial and
more animal studies are needed.
1.1.3 The Amygdala
An important part of the limbic system in the brain is the amygdala. This brain
area serves as the major interface between the sensory experiences, such as
seeing an aggressor and perceiving indications of its harmful intentions and the
biochemical and behavioural systems that respond to this information (Le Doux,
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81990). The amygdala determines whether there should be a stress response or
not, and activates the neuroanatomical and neurochemical circuitry of fear
(Davis, 1992). Projections from the central amygdala to the bed nucleus of the
stria terminalis and hypothalamus initiate the HPA-axis response, and projections
to the nucleus accumbens (part of the basal ganglia) influences motor responses
(Crossman & Neary, 1995). The amygdala, which is important in the control of
emotional and autonomic responses to stress, receives its information through
lateral and basolateral nuclei (Davis, 1992), Fig.1.2.
BLA
Behavioral Test or Sign ot
Anatomical Target Fear or Anxiety
Lateral hypothalamus ----I~..Tachycan:lia, galvaniC) $kin response,
. paleness, pupll dilation. blood pl'essure elevation
OOr.. !motor N. ot vagus
Nucleus amblQU\Js ::.;;;.;..-----l..... Ulcers, urinath)n,defecation, ~Cárdl.a
Parabrs.chl.al nw::leus __ -I~" Panting,. respiratory distress
~~:c=,!':1 &réS ~----l". BehavIoral and eEG arousal.
t--- ~:r~o~:I~.gtMntal N. I~~~:=~ :1'lo~
N, Retlo:ul.arls pontls cauclalls _.. 11lr;rea$edStarUe
Cc,nlral gray ------l'..... Freezing, ëOhflliCt test, eER,
social tntcracuon, hypoalgesia
Triglmlillal, FacJaImotor N,---" Fadal expreS!Slons of fttar
Paravenlrictdar N. (HypolhAl.) -. Corticosteroid release ("Sttcu response")
(Allhough mo*tly vla SNST)
Fig. 1,2. The bed nucleus of the stria terminalis and central nudeus of the amyg-
dala receive projections from the basolateral amygdala and project, in
turn, to downstream target areas that mediate behavioural, autonomic
and electrophysiological consequences of fear and anxiety,
(From: Walker et aI., 2003).
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9It is evident from several studies that the amygdala facilitates the HPA response:
In rats, electrical stimulation of the central amygdala (CeA) causes a rise in
plasma ACTH and corticosterone levels (Feldman & Weidenfeld, 1998), and
lesions of the amygdala attenuates HPA responses to stress (Feldman &
Weidenfeld, 1998; Prewitt & Herman, 1994). Chronic implantations of
corticosterone in the CeA caused corticosterone levels to be significantly
elevated 45 and 90 min post stress in comparison to controls (Shepard et aI.,
2003).
1.1.3.1 CRF and corticosterone in the amygdala
CRF release from brain regions such as the amygdala may be important for the
stress response. The amygdala contains high levels of CRF receptors (De
Souza et aI., 1985), cell bodies (Cummings et aI., 1983) and nerve terminals
(Uryu et aI., 1992). A study by Chalmers et al. (1995) showed that the greatest
density of CRF1 mRNA in the amygdala, is situated in the basolateral nucleus
(SLA). In the SLA, a disruption of inhibitory neurotransmission, by injection of a
y-amino-butyric-acid (GASA) antagonist bicuculline methiodode in rats, induces
behavioural and physiological responses similar to that seen in patients with
anxiety disorders (Sanders & Shekar, 1995). Acute bilateral injections of CRF or
urocortin in the SLA also reduced social interaction time of rats (Sajdyk et aI.,
1999).
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The role of CRF in the central nucleus of the amygdala has also been
investigated and bilateral injection of a-helical CRF (a CRF antagonist) in the
CeA reduced the freezing time of rats after re-exposure to a shock box (Swiergel
et aI., 1993), while a reduction in exploration of the open arms of the elevated
plus-maze following ethanol withdrawal, was antagonized by bilateral infusion of
the antagonist (Rassnick et aI., 1993). Rats injected bilaterally with CRF at the
dorsal margin of the amygdaloid complex exhibited decreased exploration and
rearing in the open field (Liang & Lee, 1988). Hauger et al. (1993) showed that
chronic intracisternal CRF administration also decreased CRF receptor density in
the amygdala.
Neurons in the amygdala express both type 1 and type 2 corticosteroid
receptors, with the highest density in the CeA (Morimoto et aI., 1996).
Chronically elevated corticosterone increases CRF mRNA in the central
amygdala (Makino et aI., 1994; Shepard et aI., 2000), and this upregulation may
contribute to anxiety-like behaviours observed with elevated corticosterone
(Schul kin et aI., 1998). Shepard et al. (2000) investigated the effect of bilateral
corticosterone implants in the CeA of rats and found that after 7 days, the rats
exhibited a decrease in exploration of the open arms of the elevated plus-maze
indicating an anxiogenic effect of corticosterone. Similarly, Greenwood-Van
Meerveld et al. (2001) found increased measures of anxiety in a different rat
strain after chronic corticosterone implants. These studies indicate that the
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interaction between eRF and/or corticosterone and the amygdala may contribute
to the establishment of behavioural abnormalities.
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1.1.4 Psychiatric disorders
Psychiatric disorders are common internationally, and an estimated 22.1% of
Americans above the age of 18 are diagnosed with a mental disorder in a given
year (Regier et aI.,1993). When this figure is applied to the 1998 United States
census residential population estimate, it translates to 44.3 million people
(Narrow, 1998). Additionally, 4 of the 10 leading causes of disability in the United
States are mental disorders (Murray & Lopez, 1996). The anxiety disorders
accounts for one third of the total costs of all the psychiatric disorders (Dupont et
aI., 1996). Psychiatric disorders are probably a result of a complex interaction of
genetic, behavioural and developmental factors. In order to develop better
treatments, animal studies and clinical trials are used to pinpoint specific brain
areas and neurotransmitters involved in anxiety and fear, the two behaviours that
underlie anxiety and depressive disorders.
1.1.5 Psychiatric disorders and HPA-dysfunction
Conditions directly associated with impairment in the regulation of stress systems
are most likely to be anxiety and depressive disorders (Sullivan & Gratton, 2002).
Patients with anxiety disorders such as posttraumatic stress disorder (PTSD),
panic disorder and obsessive-compulsive disorder (OCD), as well as patients
diagnosed with major depression show symptoms of a dysregulated HPA-axis.
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Several studies support the hypothesis of hypersecretion of GRF in anxiety
disorders and depression (Nemeroff et aI., 1984). Various clinical studies have
also been done to determine baseline plasma and urinary cortisol levels, as well
as AGTH and cortisol levels after a challenge, in patients and compared it to
normal persons.
1.1.5.1 Anxiety disorders
Each of the anxiety disorders has a component comprising anxiety symptoms:
1. In PTSD, after a traumatic event, patients re-experience the past event
2. In OGD, patients have obsessive thoughts that increase anxiety and
compulsive behaviours help to decrease anxiety
3. Panic disorder patients develop spontaneous periods of anxiety called panic
attacks (Stein & Hugo, 2002).
1.1.5.20GD
Elevated baseline levels of plasma cortisol (Monteleone et aI., 1995) and urinary
free cortisol (Gehris et aI., 1990) were measured in OGD patients. Altemus et al.
(1992) measured elevated cerebrospinal fluid (GSF) concentrations of GRF in
adult OGD patients compared to controls, while Fossey et al. (1996) measured
increased GRF only in male patients. A blunted AGTH response was observed
after GRF administration, suggesting a chronic increase in GRF release resulting
from a hyperactive HPA-axis (Servant, 1997).
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1.1.5.3 Panic Disorder
Most studies found elevated or normal basal cortisol plasma levels in patients
with Panic Disorder (Charney & Bremner, 1999). Similarly, Marshall et al. (2002)
measured significantly elevated baseline cortisol levels in panic patients vs.
controls, but CSF levels of CRF were not elevated (Jolkkonen et aI., 1993;
Fossey et aI., 1996). A blunted ACTH response was observed after CRF
administration, similar to that observed in patients with OCD (Servant, 1997).
1.1.5.4 PTSD
Studies on PTSD patients showed decreased urinary cortisol levels compared to
controls (Mason et aI, 1986; Yehuda et al. 1990, 1995) and, although results are
conflicting, a majority of studies observed decreased baseline plasma cortisol
levels in PTSD patients (Boscarino, 1996; Stein et aI., 1997; Goenjian et aI.,
1996, Marshall et al. 2002). CSF concentrations of CRF are normally higher in
PTSD patients than in healthy persons and could be an indication of a
hyperactive hypothalamus (Bremner et aI., 1997). A blunted ACTH response to
CRF is also observed in PTSD patients (Smith et al., 1989; DeBellis et aI., 1994).
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1.1.5.5 Depression
Depressive patients show increased basal cortisol as well as increased levels of
CRF in their CSF (plotsky et al., 1998; Wong et al., 2000). These patients, like
PTSD and panic disorder and OCD patients also show a blunted ACTH response
to CRF administration (Holsboer et al., 1986).
1.1.5.6 Extrahypothalamic CRF systems in psychiatric disorders
The above-mentioned studies provide some evidence for increased CRF
secretion in the brain. Neuropeptides appear to be secreted directly into CSF
from brain tissue, therefore CRF found in CSF is unlikely to be derived from
systemic circulation. Studies with non-human primates suggest that this
elevation in CRF concentrations may reflect function of extrahypothalamic CRF
systems (Post et al., 1982; Kalin, 1990)
1.1.6 Serotonin and psychiatric disorders
Dysfunction in serotonergic (5-HT) neurotransmission has been associated with
depression, anxiety, panic disorder and obsessive-compulsive disorder (Graeff et
al., 1997; Levy & Van de Kar, 1992). 5-HT1A Receptors are densely distributed in
limbic brain areas such as the hippocampus, amygdala and entorhinal cortex
(Pazos & Palacios, 1985) and the serotonergic input into these brain areas is
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mainly from the raphe nucleus (Vizi & Kiss, 1998). A reduced number of 5-HT1
receptors have been found in post-mortem brains of depressed suicide patients
(Gheetam et al., 1990).
Antidepressant drugs, or serotonin reuptake inhibitors, are effective in improving
both depression and anxiety, specifically in patients with DGD, panic disorder
and generalized anxiety disorder (Nutt, 1991). Effective antidepressant
treatment has been found to enhance 5-HT1A function in the hippocampus (Blier
et al., 1987; De Montigny & Blier, 1992), while acute tryptophan depletion
produces a return in depressive symptoms in 80% of treated patients (Delgado et
al., 1990). A possible mechanism may be an increase in synaptic 5-HT levels to
maximize binding to depleted 5-HT1A receptors.
Activation of postsynaptic 5-HT1A receptors inhibits various other neurons for
example GABA-ergic interneurons (Barnes & Sharp, 1999) and agonists for this
receptor subtype modulates anxiety in humans. In clinical studies, 5-HT1A
agonists have been efficient in clinical studies to reduce depression and anxiety
in depressive patients and chronic treatment does not desensitize this receptor in
the hippocampus (Blier & De Montigny 1987). One hypothesis for the efficacy of
5-HT1A agonists in both depression and anxiety, is that 5-HT transmission would
be decreased in patients with depression since the exogenous agonist would act
in synergy with the low levels of endogenous 5-HT, while the agonist would
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compete with high levels of endogenous 5-HT and decrease 5-HT transmission
in patients with anxiety (De Vry, 1995).
The hippocampus is activated by stress, since 30 min restraint stress in rats
induced c-fos mRNA expression, which is a marker of neuronal activity (Morgan
& Curran, 1991). Microdialysis studies on rats provide evidence that handling,
tail pitch and exposure to the elevated plus-maze increases 5-HT release in the
hippocampus (Bickerdike et ai., 1993; Kalen et ai., 1989). Acute stress either
increases or decreases hippocampal and/or cortical 5-HT1A receptors
(Raghupathi & Mcgonigle, 1997), and postsynaptic 5-HT1A hippocampal
receptors have been postulated to playa role in adaptation to stress (Meijer & De
Kloet, 1998). 2 Weeks of chronic, unpredictable stress also reduced 5-HT1A
receptor binding in rat hippocampi (Lopez et al. 1998). In a study on ultrasonic
vocalizations in rat pups during separation anxiety, Olivier et al. (1994) found that
both 5-HT1A agonists and SSRI's decrease the calling of the pups. Studies using
5-HT1A receptor knockout mice as a model of anxiety and depression, found that
the knockout mice are less active than controls in stressful situations, implicating
that these mice are more anxious (Olivier et ai., 2001). It is evident from these
animal studies that anxiety is regulated at least in part by the hippocampal 5-
HT 1Areceptor.
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1.2 Stereotypical Behaviour Study
1.2.1 Stereotypical behaviour
Stereotypies are described as movements that are combined into rhythmic or
complex sequences of obscure purpose and have attained a level of functional
autonomy (Woodworth, 1918). Another definition depicts them as sequences of
motor behaviour that are repetitive, topographically invariant and purposeless
(Ridley, 1994). Stereotypical behaviour is a characteristic feature of a range of
psychiatric disorders, for example obsessive-compulsive disorder, Touretle's
disorder and trichotillomania. Stereotypical behaviour is not limited to human
psychiatric disorders, but results from brain damage, environmental stimuli or as
a result of drug treatment (Mason, 1991). Although many studies on
stereotypical behaviour have been done, the complex neurobiology of this
phenomenon is stiDnot clear.
1.2.1.1 Environmental vs. drug induced stereotypies
'Cage' stereotypies, which are commonly seen in caged laboratory animals such
as rats, mice and monkeys, are elicited by the frustration of specific motivated
behaviours for example escaping the cage (Rushen et aI., 1993), in combination
with stress (Wurbel & Stauffacher, 1997), and / or a reduction in environmental
complexity (Toates, 2000). Some examples of 'cage' stereotypies are pacing,
backward somersaulting and jumping on all fours in monkeys (Berksen, 1967),
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bar gnawing and jumping in mice (Wurbel et al., 1996), backward somersaults
and jumping in bank voles (Schoenecker & Heller, 2003). These behaviours can
generally be abolished by environmental enrichment or removing the animal from
the cage. It has been proposed that stereotypies in laboratory animals serve a
coping function to reduce stress and, if this was the case, prevention of
stereotypy would increase stress levels. Kennes & De Rycke (1988) found that
bank voles with stereotypy had longer lasting and more pronounced levels of
plasma corticosterone than individuals without stereotypy, while Wurbel and
Stauffacher (1996) measured significant elevations in serum corticosterone 24h
after mice were prevented from wire-gnawing. These results therefore confirm
the stress-relieving function of stereotypic behaviour.
An animal model of OCD, acral lick dermatitis (ALO) in dogs, is an example of
environmentally induced stereotypical behaviour. The development of the
stereotypies in dogs is believed to be secondary to boredom, loneliness and
confinement (Veith, 1986). It is interesting that ALO is more likely to develop in
certain large breeds of dogs, such as Labradors, German sheperds, Great Danes
and Saint Bernards as well as in individual families of dogs. This phenomenon
suggests that some dogs are genetically predisposed to develop ALO in a similar
environment (Rapoport et al., 1992).
Psychomotor stimulant drugs such as amphetamine and apomorphine can also
induce stereotypies. These substances increase dopamine release from nerve
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terminals in the ventral (nucleus accumbens) and dorsal striatum (caudate
putamen). The stereotypy usually becomes more intense with increasing doses
of the drug (Lyon & Robbins 1975). In monkeys, amphetamine induces repetitive
movements such as self-grooming, staring at the hands, snatching the air
(Ellison et ai., 1980) and excessive grooming when injected locally in the dorsal
striatum (Robbins et al., 1990).
The dopaminergic system is not the only neurotransmitter system implicated in
stereotypical behaviour. Manipulation of postsynaptic 5-HT receptors by 5-HT
agonists also leads to stereotypical behaviour including forepaw-treading, 'wet-
dog' shakes and head weaving (Gerson & Baldasserini, 1980; Curzon, 1990).
Morphine, and other opioids given to rats and mice, induces stereotyped
locomotion and oral stereotypies (Robbins & Sahakian, 1981). Direct injections
of opiate agonists in the substantia nigra produce intense stereotypies in rats
presumably because of disinhibition of nigrostriatal dopaminergic projections
(Wood & Richard, 1982). Similarly, central injection of a large number of active
neuropeptides induces excessive grooming in rats (Isaacson & Gispen, 1990).
1.2.1.2 Animal models of psychiatric disorders
Three types of validity characterize animal models for human disorders. Face
validity of a model is where symptoms of the model are phenotypically similar to
that of the human disorder, which can be measured by behavioural changes.
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Good predictive validity of an animal model is where the animal responds to
drugs used in treatment of the human disorder and symptoms are decreased.
Construct validity refers to the underlying mechanism of the symptoms, and
whether the cause of the abnormal behaviour is similar in both the animal model
and human disorder (Overall, 2000).
1.2.1.3 Anatomy of the basal ganglia
Stereotypies are associated with basal ganglia dysfunction in the brain. The
anatomy of the brain and basal ganglia that is involved in motor control is shown
in fig. 1.3.
Neocortex
l.L..~~--- Caudate nucleus
Putamen
Pallidum
Thalamus -r-=-'--H1-4-
Subthalamic nucleus
Substantia nigra
CuIYlltl! 9;0I09't
Fig 1.3. The anatomy of the basal ganglia. (From: Graybiel, 2000)
Selection and sequencing of normal behaviour and movement is mainly
regulated by the interaction of two antagonistic cortico-striatal circuit loops in the
dorsal basal ganglia. The direct pathway activates behaviour while the indirect
pathway is inhibitory and allows for proper transitions between behaviours (Fig.
1.4). Behaviour is elicited by the activation of different subtypes of dopamine
receptors and negative feedback within the cuircuits are done by dynorphin
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releasing neurons in the direct pathway and enkephalin releasing neurons in the
indirect pathway (Alexander & Crutcher, 1990; Hauber, 1998).
(.)
Neocortex
Fig. 1.4. (a) The direct pathway consists of two successive GABAergic
connections from the striatum to the internal pallidum and from
the internal pallidum to the thalamus. Glutamate input from the
neocortex to the striatum disinhibits thalamic neurons, and
dopamine modulates the system at the level of the striatum.
(b) In the indirect pathway there is an extra step after the
external pallidum, so that the subthalamic nucleus excites
the internal pallidum.
(c) Balance is achieved when these antagonist systems are
combined under normal circumstances. (From: Graybiel, 2000).
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1.3 Aims
The aim of both these studies was to investigate possible models for psychiatric
disorders. The CRF study focused on a rat model for anxiety disorders (OCD,
PTSD and Panic Disorder) and depression. In these disorders, HPA-axis
abnormalities are common and an increase in CRF is observed in CSF of
patients. We investigated the role of elevated CRF in the SLA of rats in the
development of anxious behaviour and HPA-axis abnormalities. The
stereotypical behaviour study focused on OCD. Compulsions observed in
patients with OCD are compared with spontaneous stereotypical behaviour of
deermice. The aim was to characterize a mouse model of OCD in terms of
predictive, face and construct validity.
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Chapter 2:
Methods
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2.1 Behavioural experiments
2.1.1 The Elevated Plus-maze
The Elevated Plus-maze has been validated by various authors (Pellowet al.,
1985; Rodgers & Dalvi, 1997) and is used widely in rat behavioural studies as a
measure of anxiety and locomotor activity. Fig.2.1. shows a photograph of the
Elevated Plus Maze, which is constructed of black Perspex. The maze is
elevated half a meter from the ground, and consists of 2 opposed closed arms
(50x10x40cm) and 2 opposed open arms (50x10cm). The arms are situated at
90° angles from each other with an open square in the middle (1Ox1Ocm). The
maze is designed to test the rat's level of anxiety based on the following
principle: When placed in the maze, the animal experiences two conflicting
behavioural states. The maze provides a novel or unfamiliar environment that
the rat would like to explore, but the rat simultaneously experiences a fear of the
open spaces and height. If the rat is more anxious, it will tend to avoid the open
arms of the maze and exploratory behaviour will be reduced. At the same time
the maze can be used to test locomotor activity levels by recording the amount of
entries into the arms. Rats that are more anxious will show decreased activity
(Pellawet al., 1985; Rodgers & Dalvi, 1997).
In our study, rats were placed on the maze for 5 min. to evaluate their level of
anxiety and locomotion. The room was dark and only dim light used on the
elevated plus-maze during testing. After an acclimation period of to 1 hour to the
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behavioural test room, rats were placed in the middle of the maze, facing an
open arm, at the beginning of the 5 min time period, and an entry into an arm
was recorded when one leg crossed the line at the entrance of the arm, and out
again when all 4 legs crossed the line to the middle of the maze. This criterion
was chosen since we found that there is no significant difference in total time
when using one or two arms as entry into an arm. The maze was cleaned with a
70% ethanol solution and dried between recordings, in order to avoid the
possibility of chemical cues affecting the behaviour of the rats.
The following parameters were used for scoring: Amount of time spent in the
open and closed arms; the amount of entries into the open and closed arms;
rearing (standing on its hind paws), grooming (washing of the coat) and freezing
(absolute stillness of the rat and whiskers for 2 seconds or longer) as anxiety-
related behaviours (Escorihuela et aI., 1999). Three independent individuals
performed the scoring and rated the video recordings at the same time, each
noting a different set of behaviours.
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Fig.2.1. The Elevated Plus-maze viewed from above.
2.1.2 The Open Field test
The Open Field test is used in behavioural studies as an indication of locomotor
activity as well as anxiety of rats (Prut & Belzung, 2003; Royce, 1977). Fig.2.2
shows a photograph of the Open Field arena, which is constructed from white
perpex sides and gray floor with dimensions of 1x1xO.5m. The floor is divided
into 25 squares as well as an outer and inner zone demarcated by a line 15cm
from the sides. A fluorescent lamp is positioned above the middle of the box,
about 20cm from the ground and illuminates the inner zone while the outer zone
is dimmer. The level of anxiety of a rat is tested while moving in the Open Field,
since the more anxious the rat is, the more it tends to avoid the brightly lit inner
zone, and stays closer to the darker outer zone. The locomotor activity is
Stellenbosch University http://scholar.sun.ac.za
28
simultaneously tested as the rat moves across the floor by counting the amount
of squares crossed.
The rats were always placed in the same corner of the open field, and video
recordings were made for 5 min. Parameters that were used to test the
behaviour of the rats included the following: number of blocks crossed; time
spent in the outer zone vs. time spent in the inner zone, number of crossings
between the outer and inner zone; rearing and grooming. The light in the room
was dimmed prior to testing in the Open Field so that the effect of the lamp in the
center of the box was more pronounced. The Open Field was cleaned with a
70% ethanol solution and dried after each rat was tested.
Fig.2.2. The Open Field arena viewed from above.
Stellenbosch University http://scholar.sun.ac.za
29
2.1.3 Time of behavioural tests
In order to assess the best time to perform the behavioural experiments, 12
naïve male Wistar rats were acclimated to the test room for 1 hour and placed on
the elevated plus maze and open field (5 min each). Video recordings were
made and rated afterwards. The first group (n=4) was recorded between 10:00
and 12:00 (morning), the second group (n=4) between 14:00 and 16:00
(afternoon) and the third group (n=4) between 20:00 and 21 :00 (evening).
Locomotor activity was noted as the amount of entries into the open and closed
arms of the elevated plus maze, the amount of blocks crossed and the number of
crossings between the outer and inner zone of the open field, as well as rearing.
Statistical analyses were done using Kruskal-Wallis non-parametric test with
Dunn's multiple comparison post-hoc test. There was no significant difference in
rearing, the amount of entries in the elevated plus maze or number of crossings
between the outer and inner zone of the open field. There was, however, a
significant increase in the number of blocks crossed in rats tested in the morning
as opposed to the other two groups (p<0.05), Fig.2.3. Following this result, we
decided to record all behaviour in the morning when activity levels were highest.
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Number of blocks crossed in the
Open Field
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Fig. 2.3. Significant differences in the number of blocks crossed in the open field
morning afternoon evening
were found between rats tested in the morning and rats tested in the
afternoon or evening (* = p<0.05). Values are shown as means ± SEM.
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2.2 Stereotaxis
Stereotaxis was performed using a David Kopf stereotaxis apparatus. Rats were
left in the theatre for at least one hour before experiments. Prior to surgical
manipulation, animals were anaesthetised with equithesin (1.5ml/300g
bodyweight). When the rat was fully sedated, the hair on the head was shaved
and the area cleaned with a 70% ethanol solution. The rat was placed in the
stereotaxis apparatus, and carefully positioned by inserting the ear bars and
centering the head. The incisors were put in the incisor bar. A heating pad,
attached to a temperature controller, maintaining the heat at a temperature of
37°C, was placed under the rat. An incision was made with a scalpel, and
subcutaneous tissue scraped away with a spatula until the skull was exposed.
The surface was cleaned with saline solution, and dried with Kleenex tissue.
Using a dissecting microscope (Zeiss), the coordinates of bregma and lambda as
well as the midline were determined. The coordinates for the basolateral
amygdala were the following: Anterior-Posterior -3.3 from Bregma, Medial-
Lateral -4.6 and Dorsal-Ventral -8.7, according to the atlas of Paxinos & Watson
(1986). An electrical drill was used to drill holes in the skull, and the excess bone
was removed using forceps. Four stainless steel screws (1.6mm) were inserted
into the skull to serve as anchors in order to fix the dental cement to the skull.
The Dura Mater was punctured with a needle, and the guide cannulae were
lowered into the brain. Surgicell was inserted around the cannulae into the holes
that were drilled, and dental cement was used to fix the cannulae in this position.
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After the cement hardened, dummy cannulae were inserted into the guide
cannulae (purchased from Plastic Products Company, Virginia) and rats were left
in their home cages to recover for 3-4 days before the start of any experimental
procedures.
2.3 Histology
Histology was performed on rat brains to verify placement of the cannulae.
Histology was only performed on a number of rats since other brains were used
for dissection of the hippocampus. After rats were anaesthetized, 11J1of Indian
black ink was injected, the rats were sacrificed by decapitation and the brain
removed and stored in10% formalin solution. After fixation, the brains were
processed and imbedded in paraffin wax. The brains were sectioned (20lJm) and
stained with Heamatoxylin and Eosin. Fig. 2.4 is a photograph of a ~lide showing
unilateral implantation and Fig. 2.5 a bilateral implantation showing only the right
side of the brain.
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Fig. 2.4. Unilateral implantation in the basolateral amygdala.
Fig.2.5. Bilateral implantation in the basolateral amygdala.
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2.4 Radioligand binding
2.4.1 CRF study: serotonin (5HT)1A receptors in the rat hippocampus
The hippocampi were removed on an ice cold glass slab, snap frozen in liquid
nitrogen and stored at -BO°C until radioligand binding assays were performed
using the method of Jackson & Etgen (2001) and Keck & Lakoski (2000).
2.4.1.1 Membrane preparation
Tissue samples were weighed, thawed and suspended in 20ml cold buffer
(50mM Tris, 4mM CaCI2• pH 7,7). The sample was homogenised for 5 sec using
a Polytron. The suspension was then centrifuged in a Beckman Ultracentrifuge
(4°C) for 10 min at 15000rpm. The supernatant was discarded and the pellet
resuspended in 20 ml buffer, homogenized with a glass teflon homogeniser and
centrifuged. This process was repeated twice and before the last centrifugation,
incubated at 37°C in a shaking waterbath. The pellet was resuspended in 20
volumes buffer and homogenized using the polytron.
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2.4.1.2 Binding assay
2-(N,N-di[2,3(n)-3H]propylamino)-8-hydroxy-1 ,2,3,4-tetrahydronaphthalene ([3H]_
8-0H-OPAT) binding assays were performed at room temperature. The total
incubation volume for each tube was 500~1. Each tube contained 1OO~I
membrane suspension (1mg/ml protein), 300~1buffer and 100~1eH]-8-0H-OPAT
(197 Ci/mMol, Amersham Biosciences). A concentration range of 0.25 to 20nM
with 8 different concentrations was used for [3H]-8-0H-OPAT. Non-specific
binding was measured by adding 100~1 5-HT (20~M) instead of 100~1 buffer.
The radioligand was added in increasing concentrations and the homogenate
was vortexed before incubation for 15min at 3rC. Assays were terminated by
rapid filtration through Whatman GF/C glass fibre filters, which were saturated
with buffer before filtration. Tubes and filters were washed with cold buffer, and
filters were transferred into counting vials (Packard) and covered with 10ml Filter
Count scintillation fluid (Packard). After at least 3 hours, radioactivity on the
filters was determined using a Beckman scintillation counter. Receptor density
(Bmax) and affinity (Kd) were calculated using GraphPad Prism version 2.01.
2.4.2 Stereotypical behaviour study: NMOA receptors in the mouse frontal cortex
Frontal cortices of the brains were removed on an ice cold glass slab, snap
frozen in liquid nitrogen and stored at -80°C until radioligand binding assays were
performed on NMOA receptors using a modified method of Foster and Wong
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(1987), in collaboration with the Department of Pharmacology, North West
University, South Africa.
2.4.2.1 Membrane preparation
Tissue samples were thawed and suspended in 5ml cold buffer (100ml 5mM
HEPES and 100ml 4,5mM Tris made up to 11with distilled water, pH 7.8) and
homogenised for 6 sec using a Brinkman Polytron. The suspension was
centrifuged at 18000 rpm for 20min using a Beckman Ultracentrifuge (4°C). The
pellet was resuspended in buffer and the process was repeated twice. The final
pellet was suspended in 5ml buffer and homogenised for 6 sec.
2.4.2.2 Binding assay
[3H]MK801 binding assays were performed at room temperature. The total
incubation volume for each tube was 500~1. Each tube contained 300~1
membrane suspension, 50~1 glutamate (10~M, Sigma), 50~1 glycine (30~M,
Sigma), 50~1buffer and 50JlI [3H]MK801 (28.9 Ci/mMol, Amersham Biosciences).
A concentration range of 0.1 to 1OnMwith 8 different concentrations was used for
[3H]MK801. Non-specific binding was measured by adding 50~1 MK801 (5~M,
Sigma) instead of buffer. The radioligand was added in increasing
concentrations and the homogenate was vortexed before incubation for 90min at
room temperature. Assays were terminated by rapid filtration through Whatman
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GF/C glass fibre filters, which were saturated with buffer before filtration. Tubes
and filters were washed with cold buffer, and filters were transferred into counting
vials (Packard) and covered with 4ml Filter Count scintillation fluid (Packard).
After at least 3 hours, radioactivity on the filters was determined using a Packard
Tri-Carb 4660 counter. Receptor density (Bmax) and affinity (Kd) were calculated
using the Combicept program (Packard).
2.4.3 Protein determination
Protein determinations were done using the method described by Lowry et al.
(1951). For the standard curve, 5 concentrations of BSA (1mg/ml) were used
(Table 2.1.).
Table 2.1. Contents of tubes used for drawing a standard curve in protein
determination.
Distilled water Buffer BSA
Standard 1 9401-11 501-11 101-11
Standard 2 9301-11 501-11 201-11
Standard 3 9201-11 501-11 301-11
Standard 4 9101-11 501-11 401-11
Standard 5 9001-11 501-11 501-11
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All protein detenninations were done in duplicate, and an average value was
used for assay analyses. Sample tubes contained 9501-11distilled water and 501-11
tissue homogenate, obtained from membrane preparation for the binding assay.
1ml of Tartrate reagent (Table 2.2) was added to each tube, and incubated for 10
min at room temperature. 3ml Falin reagent (3ml folin +27ml distilled water) was
added to each tube, which was then vortexed and incubated for 10 min at 50°C.
A blank tube containing 950111distilled water and 50111buffer, was used to zero
the spectrophotometer (Spectronic 20 Genesys), and absorbance of standards
and sample tubes were read at 650nM at room temperature. The standard curve
was used to determine protein contents of tissue samples.
Table 2.2: Contents of Tartrate reagent used for protein determination.
NaOH 0.5g in 25ml distilled water
Na2C03 2.5g
K Tartrate 2.5ml of 10% solution
CUS04 250111of 5% solution
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2.5 Adrenocorticotropin Hormone (ACTH) determinations
Blood samples of rats were collected in EDTA tubes after decapitation and
centrifuged at 4°C at 5000rpm. Plasma was collected and stored in liquid
nitrogen until the assay was done. An ACTH radioisotopic assay was purchased
from Nichols Institute Diagnostics. The kit included 7 standards for establishing a
standard curve, as well as two controls. Each standard and control was assayed
in duplicate, and the average CPM was determined using a Packard gamma
counter. The plasma samples of the rats were also assayed in duplicate.
2.6 Corticosterone determinations
Blood samples of rats were collected in EDTA tubes after decapitation and
centrifuged at 4°C at 5000rpm. Plasma was collected and stored in liquid
nitrogen until the assay was done. Corticosterone determinations were done
using an ADVIA centaur system, in collaboration with the Department of
Chemical Pathology, University of Stellenbosch.
Stellenbosch University http://scholar.sun.ac.za
Chapter 3:
Corticotropin-Releasing Factor Study
40
Stellenbosch University http://scholar.sun.ac.za
41
3.1 Introduction
Psychiatric disorders are common internationally and almost 22% of adult
Americans are diagnosed with a mental disorder in a given year (Regier et ai.,
1993). This figure translates to 44.3 million people when applied to the 1998
United States census residential population estimate (Narrow, 1998). Anxiety
disorders are amongst the most prevalent of the psychiatric disorders (Kessler
et al., 1994), and they account for one third of the costs of all the psychiatrie
disorders (Dupont et al., 1996).
Patients diagnosed with certain mood and anxiety disorders show symptoms
of a dysregulated hypothalamic-pituitary-adrenal (HPA) axis. Patients
diagnosed with major depression show increased plasma cortisol and
corticotropin-releasing factor (CRF) in their cerebrospinal fluid (CSF) (Plotsky
et ai., 1998; Wong et ai., 2000) as well as a blunted adrenocorticotropin
hormone (ACTH) response to CRF administration (Holsboer et ai., 1986).
Elevated plasma or urinary cortisol levels have been observed in patients with
obsessive-compulsive disorder (OCD) (Monteleone et al., 1995; Gehris et al.,
1990) as well as in patients with panic disorder (PO) (Charney & Bremner,
1999; Marshall et al., 2002). However, in patients with posttraumatic stress
disorder (PTSO), decreased levels of urinary (Mason et ai, 1986; Yehuda et
ai, 1990, 1995) and plasma cortisol levels have been observed (Boscarino,
1996; Stein et al., 1997; Goenjian et al., 1997; Marshall et al., 2002). A
blunted ACTH response to CRF administration is observed in OCD, PO and
PTSD patients (Servant, 1997; Smith et el., 1989; DeBellis et ai., 1994;
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Bremner et a/., 2003). Elevated concentrations of CRF have been found in
CSF of both OCD and PTSD patients (Altemus et a/., 1992; Fossey et a/.,
1996; Bremner et a/., 1997) but not in PO patients (Fossey et a/., 1996;
Jolkkonen et a/., 1993).
These studies provide evidence for increased CRF secretion in the brains of
some patients with psychiatric disorders and, since neuropeptides appear to
be secreted directly into CSF from brain tissue, CRF found in CSF is unlikely
to be derived from systemic circulation (Post et a/., 1982). It is therefore
suggested that these elevated concentrations of CRF reflect
extrahypothalamic CRF systems (Kalin, 1990).
CRF administered intracerebroventricularly (ICV) in rats produce a dose-
dependant behavioural activation when rats are tested in a familiar
environment. When CRF injected rats are exposed to a novel environment,
they show behaviour reminiscent of that observed during stress (Koob &
Heinrichs, 1999).
The amygdala is part of the limbic system in the brain and is important in the
regulation of stress responses through its excitatory influence on the
hypothalamus as indicated by a rise in plasma ACTH and corticosterone
levels after electrical stimulation of the central nucleus (Feldman &
Weidenfeld, 1998). The amygdala also influences motor responses via
connections to the nucleus accumbens (Crossman & Neary, 1995). The
amygdala contains high levels of CRF receptors (De Souza et a/., 1985), cell
Stellenbosch University http://scholar.sun.ac.za
43
bodies (Cummings et a/., 1983) and nerve terminals (Uryu et ai., 1992).
Chalmers et a/. (1995) showed that the greatest density of CRF1 mRNA in the
amygdala is found in the basolateral nucleus (BLA). Acute bilateral CRF or
urocortin (a peptide similar to CRF) injections in the BLA reduced social
interaction time in rats (Sajdyk et a/., 1999) and chronic administration of
urocortin also increased anxiety (Sajdyk et a/., 2003). Disruption of inhibitory
neurotransmission in the BLA, by injection of a GABA antagonist, induced
behavioural and physiological responses in rats similar to that seen in patients
with anxiety disorders (Sanders & Shekar, 1995).
The aim of this study was therefore to determine the effect of chronic
injections of CRF in the BLA on the behaviour and HPA-axis response of rats.
In addition to this, serotonin (5-HT) 1A receptor activity in the hippocampus
was determined as 5-HT1A agonists have been efficient in clinical studies to
reduce both anxiety and depression and it has been shown to enhance these
receptors in the hippocampus (Blier & De Montigny, 1987). Kagamiishi et a/.
(2003) also showed that CRF injected ICV increased levels of serotonin in the
hippocampus and this elevation was attenuated by injection of a 5-HT1A
agonist prior to CRF injection. The present study therefore hypothesized that
chronic elevation of CRF levels in the BLA would lead to behavioural, HPA-
axis and serotonin abnormalities normally associated with anxiety disorders or
depression.
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3.2 Materials and Methods
3.2.1 Animals
Male Sprague-Dawley and Wistar rats were bred and housed in the animal
facility of the University of Stellenbosch Medical School. The rats were kept
under standard laboratory conditions with free access to food and water.
3.2.2 Unilateral injections
Stereotaxis and behaviour
Male Sprague-Dawley rats weighing 250-300g were used for unilateral
stereotaxical implantations in the basolateral amygdala. Rats were
acclimated to the theatre 1 hour before the procedure. Rats were implanted
in the right basolateral amygdala at coordinates: Anterior-Posterior -3.3 from
Bregma, Medial-Lateral -4.6 and Dorsal-Ventral -8.7 according to the atlas of
Paxinos & Watson (1986). Histology was done to verify the accuracy of the
implantations. Rats were singly housed after the operation for handling
purposes, and left to recover for 3-4 days before the injection period. Rats
were randomly divided into 3 groups and received saline (n=6), 10ng CRF
(n=7) or 100ng CRF (n=6) injections daily for 5 days, between 8:00 and 11:00
in the morning. After injection, a period of 2 min was allowed for infusion of
the fluid before the needle was removed from the cannula. On day 5, video
recordings were made of the behaviour of the rats in the elevated plus-maze
and open field.
Stellenbosch University http://scholar.sun.ac.za
45
3.2.3 Bilateral injections
Stereotaxis and behaviour
Male Wistar rats weighing 300-350g were stereotaxically implanted with
chronic bilateral cannulae in the basolateral amygdala. The coordinates used
were: Anterior-Posterior -3.3 from Bregma, Medial-Lateral ±4.6 and Dorsal-
Ventral -8.7 from the surface of the skull according to the atlas of Paxinos &
Watson (1986). Histology was done to verify the accuracy of the
implantations. The rats were singly housed and allowed to recover for 4 days
before injections. Rats were randomly divided into 2 groups, receiving either
1~I saline injections (n= 17) or 1OOng/~1eRF injections (n=19) daily for 5 days
between 8hOO and 11hOO. This dosage of eRF was chosen as it yielded
significant results in the unilaterally injected rats. On day 5, 1 hour after the
last injection, the behaviour of the rats was recorded for 5 min on the elevated
plus-maze and open field. The behaviour of the first group of animals was
tested at baseline levels, n=6 for saline injected rats and n=7 for eRF injected
rats. A second group of animals were tested after restraint stress for 5 min
(fear potentiated behaviour; Korte & De Boer, 2003), n=11 for saline injected
rats and n=12 for eRF injected rats. Three evaluators rated video recordings
afterwards, each noting a different set of parameters.
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3.2.4 Stress response
On day 8, between 8:00 and 12:00 in the morning, rats were subjected to 10
min restraint stress, and decapitated either 15 min post stress (n=6 for control;
n=7 for CRF) or 60 min post stress (n=5 for control; n=6 for CRF). A third
group was decapitated at baseline levels (not subjected to restraint stress;
n=6 for each group). Trunk blood was collected in ethylenediaminetetraacetic
acid (EDTA) tubes for corticosterone and ACTH assays using a glass funnel.
Blood was kept on ice and centrifuged at 4°C at 5000 rpm and 1ml plasma
was collected and stored in liquid nitrogen until the assays were done. A
group of naïve rats was also decapitated at baseline (n=6), 15 min post stress
(n=6) and 60 min post stress (n=6), to compare their levels of ACTH and
corticosterone to that of the injected rats in order to see if the operational
procedures had any effect on HPA-activity. ACTH determinations were done
using a radioisotopic assay purchased from Nichols Institute Diagnostics,
while corticosterone levels were determined using an ADVIA centaur system.
3.2.5 Receptor binding
After decapitation, brains of bilateral injected rats were removed, dissected on
ice and hippocampi were stored in liquid nitrogen until radioligand binding
assays were performed on 5-HT1A receptors. Hippocampi were pooled (2
animals per group) to increase the sensitivity of the assays (n=6 for control
and CRF).
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3.2.6 Statistical analyses
Statistical analyses for behaviour were done using Mann-Whitney U tests or
Kruskal-Wallis tests. Data for the stress response was analysed using
Kruskal-Wallis tests. Receptor binding data was analysed using Student's t-
test.
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3.3 Results
3.3.1 Unilateral injections
Unilateral injections of eRF induced a significant increase in the number of
entries into the open arms of the elevated plus-maze in the eRF 100ng group
(p<O.05), Fig. 3.1. There was also a significant increase in the time spent in
the open arms of the elevated plus-maze in the eRF 100ng group (p<O.05),
Fig. 3.2. There were no significant differences in the amounts of rearing,
freezing or grooming between any of the groups (p>O.05), Fig. 3.3.
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Fig. 3.1. There was a significant increase in the number of entries into the
open arms of the elevated plus-maze in the eRF 100ng group
(* = p<O.05). There were no significant differences in the number
of entries into the closed arms of the elevated plus-maze between
any of the groups. Values are shown as means ± SEM.
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Fig.3.2. There was a significant increase in the amount of time spent in the
open arms of the elevated plus-maze (* = p<O.05) in the eRF 100ng
group. There was no significant differences in the amount of time
spent in the closed arms of the elevated plus-maze. Values are
shown as means ±SEM.
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Fig. 3.3. There were no significant differences in rearing, freezing and
grooming behaviour in the elevated plus-maze. Values are shown
as means ± SEM.
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There were no significant differences in time spent in the inner or outer zone
of the open field between any of the groups (p>0.05), Fig. 3.4. There were
also no significant differences in the number of blocks crossed in the open
field or the amount of crossings between the outer and inner zones of the
open field between any of the groups (p>0.05), Fig. 3.5. There was no
significant difference in the amount of rearing and freezing behaviour in the
open field (p>0.05), Fig. 3.6.
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Fig. 3.4. No significant differences were found between groups in time spent
in the outer or inner zone of the open field. Values are shown as
means ± SEM.
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Fig. 3.5. There were no significant differences in the amount of blocks
crossed or the number of crossings between zones in the open
field. Values are shown as means ± SEM.
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Fig. 3.6. There were no significant differences in the amount of rearing or
freezing behaviour measured in the open field. Values are shown
as means ± SEM.
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There were no significant differences in elevated plus-maze (Fig. 3.7-3.9) and
open field behaviour (Fig. 3.10-3.12) of rats that were not stressed before
measuring their behaviour (p>0.05).
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Fig.3.7. No significant differences were found between groups for
number of entries into the open or closed arms of the elevated
plus-maze. Values are shown as means ± SEM.
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Fig. 3.8. No significant differences were found between groups for
the amount of time spent in the open and closed arms of the
elevated plus-maze. Values are shown as means ± SEM.
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Fig. 3.9. No significant differences were found between groups in
rearing or grooming behaviour in the elevated plus-maze.
Values are shown as means ± SEM.
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Fig. 3.10. No significant differences were found between groups in time
spent in the outer and inner zones of the open field. Values are
shown as means ± SEM.
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Fig. 3.11. No significant differences were found between groups for the
amount of blocks crossed and crossings between the inner and
outer zones in the open field. Values are shown as means ± SEM.
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Fig. 3.12. No significant differences were found between groups for rearing
and grooming behaviour in the open field. Values are shown as
means± SEM.
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There were no significant differences between groups in elevated plus-maze
behaviour of fear-potentiated rats (p>O.05), Fig. 3.13 - 3.15. There was no
significant difference in time spent in outer or inner zones of the open field
(Fig. 3.16), number of blocks crossed or crossings between the outer and
inner zone of the open field (Fig. 3.17), and rearing behaviour (Fig. 3.18).
There was, however, a significant increase in the amount of times the eRF
injected rats displayed grooming behaviour (p<O.05), Fig. 3.18.
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Fig. 3.13. No significant differences were found between groups for the
number of entries into the open and closed arms of the elevated
plus-maze. Values are shown as means ± SEM.
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Fig.3.14. No significant differences were found between groups for time
spent in the open and closed arms of the elevated plus-maze.
Values are shown as means ± SEM.
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Fig.3.15. No significant differences were found between groups for
rearing and grooming behaviour in the elevated plus-maze.
values are shown as means ± SEM.
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Fig. 3.16. No significant differences were found between groups for time
spent in the outer and inner zones of the open field. Values
are shown as means ± SEM.
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Fig.3.17. No significant differences were found between groups for
the number of crossings and crossings between the outer and
inner zones of the open field. Values are shown as means ± SEM.
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Fig. 3.18. A significant increase in the amount of grooming bouts in the
open field was found in eRF injected rats compared to control
rats (* = p<O.05). No significant difference were found between
groups for rearing behaviour. Values are shown as means
±SEM.
Stellenbosch University http://scholar.sun.ac.za
3.3.3 Stress response
59
The ACTH and corticosterone response to stress of the CRF group was
normal compared to naïve and control rats. As evident from the graphs, both
ACTH and corticosterone values increased to peak values 15 min after stress
and returned to basal levels 60 min after stress. There were no significant
differences between the groups in ACTH values at any of the time points
(p>0.05) Fig. 3.19. The basal corticosterone level of the CRF injected rats
was significantly lower compared to the control group (p<0.05), but there was
no significant differences 15 and 60 min post stress (Fig. 3.20).
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Fig. 3.19. Plasma ACTH concentrations at baseline, 15 min and 60 min after
restraint stress. Values are shown as means ±SEM. There were
no significant differences between the groups.
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Fig.3.20. There was a significant decrease in basal corticosterone levels
of eRF injected rats compared to controls (* = p<0.05). There
were no significant differences between the groups 15 or 60 min
post stress. Values are shown as means ± SEM.
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3.3.4 Receptor binding
There were no significant differences in the Bmax (Fig. 3.21) or ~ (Fig. 3.22)
values of 5-HT1A receptor populations in the hippocampus of CRF-injected
and control rats (p>O.05).
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Fig.3.21. Bmax values of 5-HT1A receptors in the hippocampus
of control and CRF injected rats. Values are shown as
means ± SEM. No significant differences were found.
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Fig. 3.22. ~ values of 5-HT1A receptors in the hippocampus
of control and CRF-injected rats. Values are shown
as means ± SEM. No significant differences were found.
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3.4 Discussion
The elevated plus-maze is commonly used in rat behavioural studies to
measure anxiety as well as locomotor activity (Rodgers & Dalvi, 1997; Pellow
et al., 1985). The more important parameters for anxiety is time spent in the
open and closed arms of the maze. In addition, rearing, freezing and
grooming are also used to differentiate between levels of anxiety (Escorihuela
et al., 1999). Locomotor activity is assessed by counting the amount of
entries made into the open and closed arms of the maze. The open field test
is used mainly for measuring locomotor activity, but may also indicate anxious
behaviour (Prut & Belzung, 2002). Number of blocks crossed in a 5 min
period is used as a measure of activity, while rearing and grooming as well as
time spent in the inner vs. outer zone can be indicators of anxiety.
3.4.1 Unilateral injections
When we injected rats unilaterally with 1DOng of CRF for 5 days, we found
that they were less anxious than controls as indicated by an increase in the
amount of time spent in the open arms of the elevated plus maze. An
increase in the amount of entries also indicates a higher activity level than
controls. Song et al. (1995) also found chronic ICV injections of 0.1, 0.5 and 1
IJg to dose dependently increase activity and rearing in the open field.
Similarly, Linthorst et al. (1997) reported increased activity after chronic
infusion of 1IJg/day for 7 days. It is evident from these studies that dosages
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up to 1 ~g/day induced decreased levels of anxiety while it increased
locomotor activity. Interestingly, similar studies with higher dosages of CRF
injected ICV resulted in decreased locomotor activity and/or increased anxiety
in the elevated plus-maze (Buwalda et al., 1997; Song et al., 1995). Acute
ICV injections of CRF showed that 0.3 and 3 ~g of CRF dose dependently
increased grooming and locomotion in a novel environment and the effect of
CRF was seen in both novel and familiar environments (Sherman & Kalin,
1987). Our initial results of increased exploration and locomotion in unilateral
injected rats are therefore in agreement and confirm the findings obtained with
low CRF concentrations. These results suggested that mild elevations of
CRF in the brain led to a state of arousal and relaxation and that the BLA
contributes to this emotional state.
3.4.2 Bilateral injections
Contrary to what we expected, bilateral injection of 100ng CRF did not
enhance the effects obtained with unilateral injections. Most of the findings
obtained with unilateral injections were lost, with only a significant increase in
grooming recorded with the open field test. An increase in number of
grooming bouts, as observed in CRF injected rats that were stressed before
behavioural testing, is usually interpreted as decreased anxiety levels. In
contrast to our findings, Sajdyk et al. (2003) found increased social anxiety in
rats in the social interaction test after chronic bilateral administration of
urocortin to the BLA. Reduced social interaction time was also observed after
acute CRF or urocortin injections in the SLA (Sajdyk et al., 1999). These
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results could indicate that the social interaction test is more sensitive than our
behavioural tests. Liang & Lee (1988) observed decreased exploration and
rearing in the open field after acute bilateral CRF injection at the dorsal
margin of the amygdala. Shepard et al. (2000) implanted corticosterone
bilaterally in the central nucleus of the amygdala (CeA) and also found
reduced open arm exploration in the elevated plus-maze. Similarly, increased
anxiety in the elevated plus maze was measured in Fisher-344 rats after
chronic corticosterone implants (Geenwood-Van Meerveld 2001). These
results indicate that corticosterone is also important in the amygdala in
modulating animal behaviour.
After we observed no increase in anxiety in the elevated plus-maze in our first
group of rats, we employed the fear-potentiated strategy in the second group
of rats by restraininq the animals for 5 min prior to behavioural testing. An
unconditioned stressor prior to behavioural testing enhances the anxiety state
of rats in the elevated plus-maze (Korte & De Boer, 2003). The restraint
stress method has been shown to reduce exploration in the elevated plus-
maze (Heinrichs et al., 1994). Restraint stress one day before exposure to the
elevated plus-maze reduced the percentage of time spent in the open arms
and as well as the number of entries into the open arms (Martijena et al.,
1997). When we used 5 min restraint as stressor on the second group of rats,
the elevated plus behaviour again showed no significant differences to
controls.
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3.4.3 Stress response
We observed a normal ACTH and corticosterone response in CRF injected
rats compared to control and naïve rats. We expected to see a blunted
ACTH/corticosterone response to stress in the CRF injected rats because of
the stimulatory effect of the amygdala on the HPA-axis causing a
downregulation of CRF receptors in the pituitary through negative feedback
inhibition. This effect has previously been observed in CRF-injected rats after
10 min of restraint stress. The level of ACTH was lower 15 min after stress in
rats chronically injected ICV (Pietersen, 2001). Our observations suggest that
injection of CRF in the BLA did not significantly increase its stimulatory effect
on the HPA-axis to the extent that pituitary receptors are downregulated.
Interestingly it has been shown that corticosterone regulates CRF in the
amygdala (Honkaniemi et ai., 1992), and chronic implants of corticosterone in
the CeA in rats produces a prolongation of corticosterone release 45 and 90
min post stress (Shepard et ai., 2003). In this study, the stress response was
tested after 7 days, suggesting that a blunted response may therefore only be
observed after a longer period of elevated CRF in the amygdala. It is possible
that the duration of the CRF injections in our study was too short to change
receptor populations at the level of the pituitary.
We found that CRF-injected rats had a significantly lower basal corticosterone
value compared to saline-injected rats. This is an interesting observation
since patients with PTSD may also have lower basal cortisol levels compared
to normal individuals (Boscarino, 1996; Stein et ai., 1997; Goenjian et ai.,
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1997; Marshall et ai., 2002). Increased, persistent negative feedback
inhibition is most likely the cause of decreased release of cortisol from the
adrenal gland. This takes place after activation of the HPA-axis and the
subsequent· release of cortisol acts on receptors in the hippocampus,
amygdala, pituitary and hypothalamus (De Kloet & Reul, 1987).
Mineralocorticoid receptors (MR) and glucocorticoid receptors (GR) are found
in equivalent numbers in the hippocampus (Dioro et ai, 1993) and the
hippocampus has an inhibitory effect on the HPA-axis (Jacobson & Sapolsky,
1991; Dallman; 1993). While MR are involved in the regulation of basal HPA-
activity, GR are occupied during stress and high levels of circulating
corticosterone in rats (McEwen et ai., 1986; De Kloet et ai., 1998). The frontal
cortex also' exerts an inhibitory effect on the HPA-axis, but rats with
corticosterone implants in this region showed only a blunted ACTH and
corticosterone effect after stress, but no effect on basal HPA-axis activity
(Dioro et ai., 1993). As expected, the frontal cortex has a 4 to 5 fold higher
concentration of GR compared to MR (Meany & Aitken 1985) and is more
likely to be involved in negative feedback inhibition during times of stress.
Patients with PTSD generally have an increased lymphocyte GR number, and
it has been hypothesised that PTSD is associated with increased sensitivity of
the HPA-axis to negative feedback inhibition (Yehuda et ai., 1991; 1993).
Hypersecretion of CRF activates the HPA-axis and increased sensitivity of GR
receptors in PTSD patients causes the HPA-axis to become progressively
more sensitive to cortisol (Yehuda, 1998). Besides increased negative
feedback sensitivity of the HPA-axis, other mechanisms have been proposed
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for decreased basal cortisol in PTSD. The first mechanism could be reduced
biosynthesis of cortisol because of adrenal insufficiency. Decrease in
responsiveness of the adrenal glands could explain hypocortisolemia with no
change in cortisol response to CRF in PTSD patients (Bremner et aI., 2003).
Secondly, structural changes like atrophy or decreased volume of the adrenal
glands could cause a reduction in cortisol levels (Heim et aI., 2000). In
contrast to this, increased adrenal volumes have been found in patients with
major depression that is associated with hypercortisolemia (Nemeroff et aI.,
1993; Rubin et aI., 1995). Both these mechanisms are more likely to explain
our observation of decreased basal corticosterone in CRF-injected rats than
downregulation of pituitary receptors, since this would also cause a reduction
in ACTH levels.
3.4.4 Receptor binding
Both CRF and 5-HT are mediators of the behavioural response to stress, and
have been reported to be related to the symptoms of depression or anxiety-
related disorders (Owens & Nemeroff, 1991; Owens & Nemeroff, 1994; Stout
et aI., 2002). Activation of the serotonergic system is considered to have an
anxiogenic effect while reduction of serotonergic function is considered to
have an anxiolytic effect (Marsden, 1990). In both animal (Katoaka et al.,
1991; Rittenhouse et al., 1992) and clinical (Feighner & Boyer, 1989;
Pecknold et aI., 1989) studies, 5-HT1A receptor agonists had an anxiolytic
effect, showing an inhibitory action of these receptors on the 5-HT system.
Kagamiishi et al. (2003) showed that CRF injected ICV increased levels of
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serotonin in the hippocampus. This elevation was attenuated by systemic
injection of a 5-HT1A agonist prior to CRF injection. This finding shows that
there is an interaction between CRF and the serotonergic system and that an
increase in hippocampal 5-HT may lead to anxiety.
Further evidence for the involvement of 5-HT1A receptors in anxiety is
provided by 5-HT1A knockout mice showing increased anxiety compared to
normal mice (Olivier et al., 2001). We did not, however, find any differences
in hippocampal 5-HT1A receptors of CRF-injected and saline-injected rats.
Similarly, Montgomery et al. (2001) also found no differences in 5-HT1A
binding in the hippocampus in clinical subjects chronically exposed to high
levels of cortisol compared to normal controls. Since we did not find an
increase in anxious behaviour in CRF-injected rats either, we can assume that
the chronically injected CRF had no significant effect on 5-HT levels in the
hippocampus and therefore we did not observe any changes in the 5-HT1A
receptor population.
3.4.5 Conclusion
Our findings of decreased anxiety and increased locomotor activity in
unilateral CRF-injected rats are probably dependent on the dosage of CRF
injected, since we did not observe these effects when animals were bilaterally
injected. The same results have also been found by other authors, when they
injected low dosages of CRF (chronically or acutely) in rats, while most other
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studies using higher dosages reported anxious behaviour and decreased
locomotor activity.
Chronic CRF injections in rats caused changes in basal HPA-axis activity.
Since we did not observe a decrease in ACTH levels, we can argue that the
decreased basal corticosterone level is independent of downregulation of
receptors in the HPA-axis, and that increased CRF somehow caused adrenal
insufficiency in the rats. This finding is comparable with clinical studies on
PTSD patients showing decreased basal cortisol levels, therefore it is possible
that chronically elevated levels of CRF in the SLA is involved in the
pathophysiology of PTSD.
From previous literature it seems as if both the SLA and CeA are important in
anxiety. Our results do not directly support the involvement of the SLA in
anxious behaviour, but chronic injections of CRF in this region causes a
decreased basal corticosterone level in rats. Further research is therefore
necessary to unravel the exact nature of this finding and its relevance to
psychiatric disorders.
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Chapter 4:
Stereotypical Behaviour Study
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4.1 Introduction
Recent studies have shown that obsessive-compulsive disorder (OCD) affects 1-
2% of the adult human population, and it is therefore amongst the most common
psychiatric disorders (Micallef & Slin, 2001). OCD is characterised by intrusive
thoughts (obsessions) and repetitive behaviours (compulsions) associated with
marked distress and impairment (Saxena et al., 1998). Compulsions can be
described as unreasonable or excessive attempts to avoid anxiety caused by
obsessions (Wright & Hewlett, 1994).
Clinical neuroimaging studies on OCD patients have provided strong evidence
for the involvement of frontal-subcortical structures in the neurobiology of OCD.
In particular. cortical-striatal-thalamic-cortical (CSTC) circuitry appears to be
hyperactive in this disorder (Insel, 1992). The direct and indirect pathways of the
CSTC circuit balance each other in the control of complex motor sequences
because of activation or suppression of the thalamo-cortical pathway (Alexander
& Crutcher, 1990), but in patients with OCD, there may be an imbalance of the
two pathways (Saxena et al., 1998).
CSTC pathways are modulated by serotonergic (5-HT) neurons from the raphae
nuclei and dopaminergic (DA) neurons from the substantia nigra. There are
functional connections in the pathways of these two neurotransmitters, for
example, stimulation of 5-HT2 receptors in the substantia nigra, as well as on
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presynaptic DA projections in the frontal cortex and striatum, results in decreased
synthesis and release of DA (Wright & Hewlett, 1994; Kapur & Remington, 1996).
DA activates the direct pathway by stimulation of 01 receptors, while stimulation
of O2 receptors inhibits the indirect pathway (Gerfen et al., 1990). It is therefore
possible that abnormalities in serotonergic and dopaminergic neurotransmission
mediate OCD symptomology. OCD could perhaps also be related to a
hyperglutamatergic condition of the prefrontal cortex, since SPECT, PET and
fMRI studies show increased elevated prefrontal cortical blood flow, activation
and metabolism in OCD patients (review by Carlsson, 2000). This could possibly
be explained by an overactive, overambitious cortex since OCD patients seem to
'think too much' (Osborn 1998) and positive feedback to the CSTC pathways
(Saxena et al., 1998).
Pharmacotherapy of OCD has focused mainly on two strategies. The first
successful treatment of OCD was with clomipramine, a serotonergic tricyclic,
suggesting involvement of the 5-HT system in OCD (Fernandez-Cordoba &
Lopez-Ibor, 1967). Selective serotonin reuptake inhibitors (SSRIs) are effective
in treating this disorder (Greist et al., 1995), but only 40-60% of OCD patients
respond to this treatment. More recent studies have concentrated on combining
SSRls with other agents (Jenike et al., 1996). Dopamine antagonists, eg.
risperidone and haloperidol, in combination with SSRls have proved to be helpful
in the treatment of refractory cases (McDougle et al.,1994; McDougle et al.,
2000). Inositol, a key metabolic precursor in the phosphatidylinositol (PI) second
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messenger cycle distal to 5-HT2 receptors, has also been shown to be effective
in OCD (Fux et aI., 1996). Inositol upregulates striatal O2 and 5-HT2 receptors
trough its effects on subcellular signaling, which is not dependent on changes in
neurotransmitter levels (Einat et aI., 1999; Harvey et aI., 2002). This drug also
has anxiolytic properties and rats injected chronically showed increased time
spent in the open arms of the elevated plus-maze (Cohen et aI., 1997).
Two types OT animal models have commonly been used to study OCD: drug
induced and environmentally induced stereotypical behaviour. Stereotypies are
reminiscent of the compulsions of OCD and can be induced by DA agonists, and
this behaviour can be blocked by DA antagonists in primates (Ridley et aI.,
1979), inhibition of DA synthesis (Stolk & Rech, 1970) or destruction of DA-
containing neurons (Creese & Iversen, 1973). Similarly, rats injected with
quinpirole (02/03 agonist) exhibit compulsive checking of specific places in an
open field and clomipramine partially attenuates this behaviour (Szetchman et
aI., 1998). -Although the compulsive checking in rats is drug induced, the
neurobiology of this behaviour can be related to OCD in terms of the involvement
of both the dopamine and serotonin systems. Canine acral lick dermatitis (ALO)
is another example of an animal model of OCD as this condition has been shown
to respond to clomipramine, f1uoxetine and citalopram (SSRIs) (Rapoport et
al.,1992; Stein et ai., 1992; Stein et ai., 1998). The neurobiology of ALO is similar
to that of OCD since these animals respond more robustly to SSRI treatment
than to noradrenergic agents and the symptoms can be related to grooming
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disorder (Rapoport ef al.,1992). Similarly in equine weaving, there was
improvement after treatment with paroxetine, a SSRI. Weaving is a spontaneous
stereotypy and since it responds to SSRI treatment, this condition can be related
to OGD (Nurnberg ef ai., 1997). Haloperidol (D2 antagonist) but not clozapine
(D4 antagonist) reduced spontaneous stereotypies in bank voles (Kennes et
ai.,1988; Schoenecker & Heller, 2001), but citalopram only reduced stereotypies
in female bank voles (Schoenecker & Heller, 2003). These studies show both
face and construct validity as models of OGD in symptoms and involvement of
dopamine and serotonin systems.
A deermice model of spontaneous stereotypy was previously characterised by
Powell ef al. (1999). Deermice that were reared in standard cages developed
spontaneous stereotypies such as vertical jumping, backward somersaults and
route tracing, while mice that were reared in an enriched environment developed
these stereotypies at a lower rate and proportion; and it is thus possible to
generate two populations of the same species: a non-stereotypical and a
stereotypical group. Apomorphine induced stereotypies in a non-stereotypical
population produced stereotypies that were topographically different from
spontaneous stereotypies. Interestingly, there were no significant differences in
the D1 and D2 receptor density of the striatum between these different
populations, suggesting limited involvement of the DA system in spontaneous
stereotypies (Powell ef aI., 1999; Presti ef ai., 2002). Deermice as an animal
model for OGD, therefore has both face and construct validity, as the
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somersaulting behaviour can be related to compulsions in OCD patients and this
behaviour is only partially mediated by the dopamine system.
The aim of this study was therefore to further characterise the model in its
suitability to study OCD. We addressed the question as to whether drugs that
have been successfully used in the treatment in patients with OCD, can reduce
spontaneous stereotypical behaviour in deermice. We also examined NMDA
receptor function in the frontal cortex to gain some insight into whether these
drugs may affect the CSTC circuit and specifically thalamic glutamatergic output.
Mice were treated with risperidone, a O2 /5-HT2 antagonist, citalopram, a SSRI
and inositol, a metabolic precursor to the PI second messenger cycle.
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4.2 Materials and methods
4.2.1 Animals
40 Adult deermice, Peromyscus manicu/atis bairdii, (breeding pairs purchased
from Peromyscus Genetic Stock Center, University of South Carolina) were
raised and housed under standard laboratory conditions with a 12/12h light/dark
cycle, standard caging (29x18x13cm) with two same sex mice per cage, food
and water available ad libitum. The mice were randomly divided into four groups
comprising 6.females and 4 males each.
4.2.2 Behaviour
Intra-peritoneal injections of various treatments were given daily, from week 1,
between 13:00 and 14:00. The three treated groups received citalopram
(1mg/kg, Stein et a/., 1998), risperidone (0,1mg/kg, Rosengarten & Quartermain,
2002) and inositol (1,2g/kg, Harvey et a/., 2001) respectively and the control
group was injected with an equal volume of saline. All drugs were dissolved in
saline and the injected volumes were 0,1ml except for inositol, which was O,2ml.
Risperidone was obtained from Janssen Pharmaceutica (South Africa),
citalopram hydrobromide from Lundbeck (Denmark) and myo-inositol was
purchased from Sigma. The behaviour of the mice was recorded for 9 weeks, 5
minutes at a time, either in the morning before 11am or in the afternoon after
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4pm, for a total of 15 minutes per week. A video camera mounted on a tripod
was used for the recordings so that a top view of the cages was obtained. The
first week of recordings served as baseline (week 0) and treatment started in
week 1. A 5sec interval scoring system was used and the absence or presence
of two forms of stereotypical behaviour, backward somersaults (backflipping) and
route tracing (patterned running), were noted. Raters that were blind to the
medication status of the mice noted the behaviour. Summed ratings for each
week of the trial were compared within the groups. Inter-rater reliability was
r=0,9.
4.2.3 Receptor binding
After a weeks of treatment, the mice were decapitated and the brains removed
and snap frozen in liquid nitrogen and stored at -aooc until radioligand binding
assays were performed for NMDA receptor characterisation in the frontal
cortices.
4.2.4 Statistical analyses
Analyses of the behavioural data were done using ANOVA with repeated
measures. ~ Mann-Whitney U test was done on values for males in week a
between all groups compared to control. Data for receptor binding were
analysed using Kruskal-Wallis tests.
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4.3 Results
4.3.1 Behaviour
Fig. 4.1 shows that somersaults increased during the 8 week period in saline
treated mice. In contrast, this increase was absent in all the groups receiving
drug treatment. This effect is more noticeable in males (Fig. 4.2.). The ANOVA
showed no significant differences in the percentage of somersaults observed in
any of the groups or between groups during the 8 week trial p>O.05 (Fig. 4.1.)
and there was also no significant difference between the control group and
treatment groups when data for males and females are analyzed separately (Fig.
4.2. & 4.3.). A significant difference was found between all groups compared to
the saline group when a Mann-Whitney U test was performed on data for males
in week 8 only, with the saline group having a much higher value (p<O.0001). No
statistical analysis was done on the data for route tracing, since there were only 1
or 2 animals per group that showed this behaviour. The data shows that
risperidone decreased route tracing behaviour during week 1 and the behaviour
disappeared by week 8, while it increased or stayed more constant during some
weeks in the other groups (Fig. 4.4.).
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Fig. 4.1. Effect of treatment on number of somersaults during an 8 week
trial. There were no significant differences between groups (p>O.05)
Values are shown as means ± SEM.
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Fig. 4.2. Effect of treatment on number of somersaults during an 8 week trial
for male deermice. There is a significant difference between
control and treatment groups at week 8 (p<O.0001). Values are shown
as means ± SEM.
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Fig.4.3. Effect of treatment on number of somersaults during an 8 week
trial for female deermice. No significant differences were found
between groups (p<0.05). Values are shown as means ± SEM.
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Fig.4.4. Effect of treatment on route tracing behaviour during an 8 week trial.
Values are shown as means.
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4.3.2 Receptor binding
In all 3 treatment groups, there is a numberical increase in density of NMDA
receptors in the frontal cortex, although statistical significance was not reached,
p=O.811 (Fig. 4.5.). The affinity of NMDA receptors was increased by treatment
with risperidone (Fig. 4.6.), but again statistical significance was not reached
(p=O.759).
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Fig. 4.5. Effect of treatment on NMDA receptor density in the frontal cortex
compared to control. There were no significant differences between
groups (p>O.05). Values are shown as means ± SEM.
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Fig.4.6. Effect of treatment on NMDA receptor affinity in the frontal cortex
compared to control. There were no significant differences between
groups (p>O.05). Values are shown as means ± SEM.
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4.4 Discussion
4.4.1 Behaviour
The data for male mice clearly show how stereotypical behaviour in the control
group increased over the 8 week period, while the behaviour in treated groups
did not increase to the same extent. Stereotypies were not significantly reduced
in any of the treatment groups when compared to their baseline values.
This is not surprising as it is known that in clinical populations, drug treatment is
only partiallyeffective in OCD patients (Piccinelli et al., 1995) and only 40-60% of
patients respond to SSRI monotherapy (Goodman, 1996). In contrast, animal
studies by Schoenecker & Heller (2001) have shown that chronic treatment with
citalopram in bank voles also did not reduce spontaneous stereotypical
behaviour under undisturbed conditions, but only after acute stress.
Interestingly, while the suppressive effect of drugs was not apparent in our
female group of animals, citalopram treatment reduced stereotypical behaviour
during peak activity levels in female bank voles, but not in males (Schoenecker &
Heller, 2003). This discrepancy may be species related as dogs with ALO also
respond to chronic treatment with clomipramine, fluoxetine and citalopram
(SSRIs) (Rapoport et aI.,1992; Stein et aI.,1992; Stein et aI., 1998).
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While SSRI's are commonly used to address stereotypie behaviour, risperidone
appeared to be the most effective of the 3 drugs we used as the number of
somersaults never rised above baseline levels. Dopamine antagonists have
been shown to be effective reducers of stereotypies. Haloperidol (D2 antagonist)
at a concentration of 0,2mg/kg reduced spontaneous stereotypies in bank voles
under undisturbed conditions (Kennes & De Rycke, 1988; Schoenecker & Heller,
2001).
Inositol administration has been demonstrated to be useful in treatment of OCD
(Fux et al., 1996). In our model, inositol stabilized the degree of stereotypie
behaviour and prevented any further increases as seen in control animals.
Chronic inositol treatment did not reduce stereotypical behaviour in guinea pigs
(Harvey et al., 2001).
4.4.2 Receptor binding
It is possible that all treatments reduced the hyperglutamatergic state in the
frontal cortex that may be associated with a hyperactive eSTC circuit (review by
Carlsson, 2000). This decrease would cause an increase in receptor numbers,
and an increase, although not significant, in receptor affinity was evident in
risperidone group. A previous study with deermice showed that there was no
significant difference in the densities of striatal D1 and D2 receptors in
stereotyping and non-stereotyping populations (Powell et al., 1999), suggesting
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that these receptors may not be essential in manifesting stereotypical behaviour.
We chose to focus on the NMDA receptors in the frontal cortex as this could be
used as an iridication of thalamic output and the hyperglutamatergic state in the
frontal cortex.
Inositol induced a significant increase in D2 receptor density and a marginal
increase in 5-HT2 receptor density in the striata of guinea pigs (Harvey et al.,
2001). The mechanism by which inositol upregulates striatal D2 and 5-HT 2
receptors is not dependent on changes in neurotransmitter levels (Einat et al.,
1999), but on its effects on subcellular signaling (Harvey et al., 2002). The
upregulation .of 5-HT2 receptors on presynaptic DA projections in the striatum
would cause inhibition of DA release and subsequent upregulation of post-
synaptic DA receptors (Harvey et al., 2001). Inositol also reverses
desensitization of 5-HT2 receptors (Rahman & Neuman, 1993).
4.4.3 Conclusion
Since we had no significant reduction in stereotypies after drug treatment, it is
difficult to make any conclusions on the involvement of the DA and 5-HT
neurotransmitter systems, and their effect on glutamatergic output, in
stereotypical behaviour of deermice. The suppression of increase in
stereotypical behaviour seen in the control group could however be an indication
that both dopamine and serotonin are involved.
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Experimental stress (handling and injections) could explain why there was no
significant reduction in the amount of somersaults in the treatment groups.
Although somersaults were not reduced, it stayed constant in all treatment
groups while it increased throughout the trial in saline injected animals.
Measuring behaviour of female mice during peak activity levels could yield
significant data, as in the case of bank voles (Schoenecker & Heller, 2003). It
would also be necessary to distinguish between low and high stereotypers and
divide the treatment group accordingly in order to observe the effects of the
drugs. Furthermore, if activity levels are significantly higher during the dark
phase, the effects of the drugs could be more evident when behaviour is
observed during this phase.
The 8 week trial might have been insufficient to induce significant differences in
receptor density and affinity, and further studies with higher dosages and
investigation of striatal serotonin and dopamine receptor activity could result in
interesting observations of the specific involvement of different neurotransmitter
pathways in spontaneous stereotypical behaviour. Acute infusion of NMOA and
01 receptor antagonists into the striatum of deermice attenuated stereotypical
jumping (Presti et ai., 2003). It has also been shown that activating 5-HT2A
receptors in the frontal cortex are involved in releasing glutamate from
thalamocortical afferents (Marek et ai., 2001). It is therefore important to do
studies to target specific receptor populations such as 01, O2 and 5-HT 2 in the
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striatum, as well as 5-HT 2 in the frontal cortex, by injecting different drugs into
these areas.
Evidence in previous literature and some of our results indicate that deermice
can be employed as an animal model for OCD. Although predictive validity of
this model still needs to be investigated, this model has good face and construct
validity.
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Chapter 5:
General Conclusions
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The aim of our study was to develop two different models of psychiatric
disorders. In the first model we used adult rats and chronically injected them with
corticotropin-releasing factor (CRF) in the basolateral amygdala (BLA). Patients
with certain psychiatric disorders show hypothalamic-pituitary-adrenal (HPA) axis
abnormalities like a blunted ACTH response to CRF injection and increased or
decreased basal cortisol levels. Most patients with post traumatic stress disorder
(PTSO), obsessive compulsive disorder (OCD) and Major Depression also have
increased levels of CRF in their cerebrospinal fluid. Since the amygdala is
involved in the behavioural and endocrine response to stress, we investigated
whether elevation of CRF levels in this region could be a factor in the
development of symptoms characteristic of these psychiatric disorders.
We injected rats with CRF for 5 days and subsequently monitored their behaviour
and stress response as well as the hippocampal serotonin (5-HT)1A receptor
density and affinity. The CRF injected rats did not show an increase in stress
related behaviour when tested on the elevated plus-maze or open field.
Unilateral injections instead increased activity and induced a more relaxed state
in CRF-injected rats compared to control rats. This result is in contrast to what
other authors, also injecting CRF in the BLA, found. There are, however, a few
studies that reported increased activity and a relaxed state after
intracerebroventricular injection of CRF in rats, that correspond to our results.
We are therefore not certain of the effect of different concentrations of CRF on
Stellenbosch University http://scholar.sun.ac.za
90
the behaviour of rats and future studies should include the administration of a
wider concentration range of CRF for a longer time period.
There was no difference in the hippocampal 5-HT 1A receptor density or affinity of
CRF-injected and control rats. This indicates that the elevation of CRF in the
BLA did not alter 5-HT neurotransmission in the hippocampus. This result is
supported by the fact that we did not see an increase in anxiety in the rats, since
alteration in 5-HT transmission is associated with anxiety.
We found evidence that the chronic CRF injections could cause decreased basal
corticosterone levels in the rats. It is also evident that the mechanism causing
decreased corticosterone is independent of downregulation of pituitary
glucocorticoid receptors, since we found no alteration in basal ACTH levels or
ACTH/corticosterone levels after stress. Our results indicate that decreased
basal cortisol levels, as observed in PTSD patients, may be caused by
chronically elevated levels of CRF in the BLA, the exact mechanism, however, is
not known. We can speculate that CRF somehow caused adrenal insufficiency
in the rats, but this needs to be further investigated. If this result can be
repeated, elevated CRF in the amygdala of rats can be used to model some of
the symptoms of PTSD.
The second study used deermice showing spontaneous stereotypical behaviour
as a potential model for OCD. From previous literature it is evident that deermice
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can be useful as a model for OCD in terms of face validity, since the
spontaneous stereotypical behaviour elicited by the mice is reminiscent of
compulsions in OCD patients. It has also been shown that these stereotypies
are topographically different to drug induced stereotypies in the same species.
Therefore, we investigated whether using a model with spontaneous stereotypies
is indeed more relevant to OCD than a model with drug induced stereotypies.
In order to validate our model in terms of predictive validity, we injected adult
deermice daily for 8 weeks with risperidone, citalopram or inositol to see what the
effects of these drugs would be on stereotypical somersaulting behaviour. We
found that all three drugs suppressed an increase in stereotypies seen in the
saline injected group. Together with this result, there was a trend towards
increased receptor densities (NMDA in the frontal cortex) with all 3 treatments as
well as incre~sed affinity in the risperidone group. The increase in stereotypies
towards week 8 of the trial, as observed in the control group, was presumably
due to stress from handling and injections. Our results show some evidence for
the involvement of both dopamine and serotonin in the development of
spontaneous stereotypies. However, some of the limitations of the study included
the short duration of treatment, small group numbers and excessive stress
experienced by the animals. Therefore, to further validate this model, future
studies should focus on these shortfalls and perhaps include the central injection
of 01 and 02 antagonists as well as 5-HT agonists in the striatum.
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